The ROE (Return on Equity) of Theravance Biopharma Inc (TBPH) is -32.14%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -32.14% |
| 2023-12-31 | -25.91% |
| 2022-12-31 | 197.40% |
| 2021-12-31 | 58.89% |
| 2020-12-31 | 91.51% |
| 2019-12-31 | 105.67% |
| 2018-12-31 | 417.64% |
| 2017-12-31 | -247.74% |
| 2016-12-31 | -54.45% |
| 2015-12-31 | -74.95% |